Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopamine-producing neurons, leading to motor symptoms such as tremors, rigidity, slowed movement, and impaired balance, as well as cognitive decline.
Using CHARLS data from 2011 to 2020, researchers found that sleep duration and self-reported sleep quality were associated with Parkinson’s disease risk in middle-aged and older Chinese adults. Short sleep was linked to higher PD risk, while age-specific patterns suggested a linear association in adults aged ≤60 years and a U-shaped relationship in those aged […]
* New study from University Hospitals, Case Western Reserve University, and the Cleveland VA identifies a potential new treatment strategy for Parkinson's disease.
* Scientists found that blocking the enzyme 15-PGDH protected brain cells and improved outcomes in multiple preclinical models of Parkinson's disease.
* The findings suggest that drugs already being developed for other uses could poten…
BackgroundCardiovascular dysautonomia is a debilitating non-motor symptom of Parkinson’s disease (PD) that limits exercise capacity and neurorehabilitation outcomes. Transcutaneous auricular vagus nerve stimulation (taVNS) is an emerging non-invasive neuromodulatory therapy that modulates cardiovascular activity and could potentially serve as an adjunct to exercise, yet its physiological effects …
The New Approaches to the Treatment of Parkinson’s disease was a great success. Many thanks to everyone who attended, I’ve written a brief report of the meeting here.
Parkinson's disease occurs when nerve cells in the brain that are responsible for producing dopamine, die or become impaired. Dopamine allows the body's muscles to move smoothly, and without it, a person slowly loses control of their movements. While the current treatment options for Parkinson's help to replenish a patient's dopamine levels, they are often only a short-term fix and can have sever…
